Assembly of a ribonucleoprotein catalyst by tertiary structure capture

Science

Volumn 271, Issue 5247, 1996, Pages 345-348

  Weeks, Kevin M ^a   Cech, Thomas R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CBP2 PROTEIN, S CEREVISIAE; CYTOCHROME B; FUNGAL PROTEIN; FUNGAL RNA; MAGNESIUM; RIBONUCLEOPROTEIN; RIBOZYME; SACCHAROMYCES CEREVISIAE PROTEIN;

ARTICLE; CATALYSIS; CHEMISTRY; CONFORMATION; GENETICS; INTRON; KINETICS; METABOLISM; RNA SPLICING;

CATALYSIS; CYTOCHROME B GROUP; FUNGAL PROTEINS; INTRONS; KINETICS; MAGNESIUM; NUCLEIC ACID CONFORMATION; RIBONUCLEOPROTEINS; RNA SPLICING; RNA, CATALYTIC; RNA, FUNGAL; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 0030593036     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.271.5247.345     Document Type: Article

References (43)

1. R. F. Gesteland and J. F. Atkins, Eds. The RNA World (Cold Spnng Harbor Laboratory Press, Cold Spring Harbor, NY 1993).
2. CBP2, cytochrome b pre-mRNA processing factor 2; P. McGraw and A. Tzagoloff, J. Biol. Chem 258, 9459 (1983); A. Gampel, M. Nishikimi, A Tzagoloff, Mol. Cell Biol. 9, 5424 (1989).
3. CBP2, cytochrome b pre-mRNA processing factor 2; P. McGraw and A. Tzagoloff, J. Biol. Chem 258, 9459 (1983); A. Gampel, M. Nishikimi, A Tzagoloff, Mol. Cell Biol. 9, 5424 (1989).
4. K. M. Weeks and T. R. Cech, Cell 82, 221 (1995).
5. _, Biochemistry 34, 7728 (1995)
6. A. Gampel and A. Tzagoloff, Mol. Cell. Biol. 7, 2545 (1987), S Partono and A. S. Lewin, ibid 8, 2562 (1988); A. Gampel and T R. Cech, Genes Dev. 5, 1870 (1991).
7. A. Gampel and A. Tzagoloff, Mol. Cell. Biol. 7, 2545 (1987), S Partono and A. S. Lewin, ibid 8, 2562 (1988); A. Gampel and T R. Cech, Genes Dev. 5, 1870 (1991).
8. A. Gampel and A. Tzagoloff, Mol. Cell. Biol. 7, 2545 (1987), S Partono and A. S. Lewin, ibid 8, 2562 (1988); A. Gampel and T R. Cech, Genes Dev. 5, 1870 (1991).
9. 32P RNA and quantified with a Phosphorlmager (Molecular Dynamics).
10. -kt), where B is the size of the burst, if any, and A + B gives the endpoint.
11. A Pingoud et al., FEBS Lett 30, 1 (1973); J Carey and O. C Uhlenbeck, Biochemistry 2, 2610 (1983); X. Gu and D. V. Santi, ibid. 31, 10295 (1992); K S. Long and D M. Crothers, ibid. 34, 8885 (1995)
12. A Pingoud et al., FEBS Lett 30, 1 (1973); J Carey and O. C Uhlenbeck, Biochemistry 2, 2610 (1983); X. Gu and D. V. Santi, ibid. 31, 10295 (1992); K S. Long and D M. Crothers, ibid. 34, 8885 (1995)
13. A Pingoud et al., FEBS Lett 30, 1 (1973); J Carey and O. C Uhlenbeck, Biochemistry 2, 2610 (1983); X. Gu and D. V. Santi, ibid. 31, 10295 (1992); K S. Long and D M. Crothers, ibid. 34, 8885 (1995)
14. A Pingoud et al., FEBS Lett 30, 1 (1973); J Carey and O. C Uhlenbeck, Biochemistry 2, 2610 (1983); X. Gu and D. V. Santi, ibid. 31, 10295 (1992); K S. Long and D M. Crothers, ibid. 34, 8885 (1995)
15. Splicing assays were performed as described (4) To measure the CBP2 association rate, CBP2 and pG were added simultaneously to trace concentrations of renatured RNA. For experiments designed to measure the rate of conversion of the folded nbozyme, CBP2 was incubated with RNA for 1 hour to ensure complete binding prior to initiating splicing by addition of pG (final concentration 2 mM)
16. If the CBP2 concentration is low enough, some step involving the protein will become rate-limiting. However, this concentration must be much smaller than 0.2 nM, the lowest concentration at which we determined the association rate At such concentrations the fraction of RNA found in a complex with CBP2 would be small.
17. For example, A. R. Fersht and Y. Requena, J. Mol Biol. 60, 279 (1971).
18. K M. Weeks and T. R. Cech, Unpublished data.
19. R. A. Alberty and G G. Hammes, J. Phys. Chem 62, 154 (1957), A Fersht, Enzyme Structure and Mechanism (Freeman, New York, ed. 2, 1985), pp. 150-152, P. H. von Hippel and O. G Berg, J. Biol. Chem. 264, 675 (1989)
20. R. A. Alberty and G G. Hammes, J. Phys. Chem 62, 154 (1957), A Fersht, Enzyme Structure and Mechanism (Freeman, New York, ed. 2, 1985), pp. 150-152, P. H. von Hippel and O. G Berg, J. Biol. Chem. 264, 675 (1989)
21. R. A. Alberty and G G. Hammes, J. Phys. Chem 62, 154 (1957), A Fersht, Enzyme Structure and Mechanism (Freeman, New York, ed. 2, 1985), pp. 150-152, P. H. von Hippel and O. G Berg, J. Biol. Chem. 264, 675 (1989)
22. Dissociation rates were determined by incubating renatured RNA and CBP2 for 1 hour to ensure complete binding and subsequently trapping any protein that dissociated by addition of heparin to a final concentration of 20 to 500 μg/ml Fraction RNA bound was analyzed by filter binding (4). Dissociation rates were independent of heparin concentration. End-points were obtained from reactions in which the heparin was added before CBP2
23. -1) = 30 pM.
24. Y. Eguchi and J.-I. Tomizawa, Cell 60, 199 (1990).
25. P. P. Zarrinkar and J. R. Williamson, Science 265, 918 (1994).
26. P E. Cole and D. M. Crothers, Biochemistry 11, 4368 (1972); D. M. Crothers, P. E. Cole, C. W. Hilbers, R. G. Schulman, J. Mol Biol. 87, 63 (1974).
27. P E. Cole and D. M. Crothers, Biochemistry 11, 4368 (1972); D. M. Crothers, P. E. Cole, C. W. Hilbers, R. G. Schulman, J. Mol Biol. 87, 63 (1974).
28. P. C Bevilacqua, R Kierzek, K A. Johnson, D. H Turner, Science 258, 1355 (1992); D. Herschlag, Biochemistry 31, 1386 (1992); Y. Li, P. C. Bevilacqua, D Mathews, D H Turner, ibid. 34, 14394 (1995)
29. P. C Bevilacqua, R Kierzek, K A. Johnson, D. H Turner, Science 258, 1355 (1992); D. Herschlag, Biochemistry 31, 1386 (1992); Y. Li, P. C. Bevilacqua, D Mathews, D H Turner, ibid. 34, 14394 (1995)
30. P. C Bevilacqua, R Kierzek, K A. Johnson, D. H Turner, Science 258, 1355 (1992); D. Herschlag, Biochemistry 31, 1386 (1992); Y. Li, P. C. Bevilacqua, D Mathews, D H Turner, ibid. 34, 14394 (1995)
31. S J Talbot and S Altman, ibid 33, 1406 (1994).
32. CYT18, mitochrondnal tyrosyl tRNA synthetase which facilitates splicing of group I introns in Neurospora crassa; R. J. Saldanha, S. S. Patel, R Surendran, J C Lee, A. M Lambowitz [ibid. 34, 1275 (1995)] observed rapid formation of an initial CYT18 pre-nbosomal RNA complex characterized by a second-order rate constant, in contrast to our observations with bl5 RNA. These data emphasize that there exist alternate pathways for simple RNP assembly.
33. T. Powers and H. F. Noller, RNA 1, 194 (1995); V. Mandiyan, S. J. Tumminia, J. S. Wall, J. F. Hainfield, M. Boublik, J. Mol. Biol. 210, 323 (1989).
34. T. Powers and H. F. Noller, RNA 1, 194 (1995); V. Mandiyan, S. J. Tumminia, J. S. Wall, J. F. Hainfield, M. Boublik, J. Mol. Biol. 210, 323 (1989).
35. M. Nomura, S. Mizushima, M. Ozaki, P. Traub, C V. Lowry, Cold Spring Harbor Symp. Quant. Biol. 34, 49 (1969); W. A Held, B. Ballou, S. Mizushima, M. Nomura, J. Biol. Chem. 249, 3103 (1974); T. Powers, G. Daubresse, H. F. Noller, J Mol. Biol. 232, 362 (1993)
36. M. Nomura, S. Mizushima, M. Ozaki, P. Traub, C V. Lowry, Cold Spring Harbor Symp. Quant. Biol. 34, 49 (1969); W. A Held, B. Ballou, S. Mizushima, M. Nomura, J. Biol. Chem. 249, 3103 (1974); T. Powers, G. Daubresse, H. F. Noller, J Mol. Biol. 232, 362 (1993)
37. M. Nomura, S. Mizushima, M. Ozaki, P. Traub, C V. Lowry, Cold Spring Harbor Symp. Quant. Biol. 34, 49 (1969); W. A Held, B. Ballou, S. Mizushima, M. Nomura, J. Biol. Chem. 249, 3103 (1974); T. Powers, G. Daubresse, H. F. Noller, J Mol. Biol. 232, 362 (1993)
38. W A. Held and M Nomura, Biochemistry 12, 3273 (1973). Assembly of the large subunit of the ribosome involves two rate-limiting unimolecular transitions [G. Sieber and K H. Nierhaus, ibid 17, 3505 (1978)].
39. W A. Held and M Nomura, Biochemistry 12, 3273 (1973). Assembly of the large subunit of the ribosome involves two rate-limiting unimolecular transitions [G. Sieber and K H. Nierhaus, ibid 17, 3505 (1978)].
40. F Michel and E Westhof, J Mol. Biol. 216, 585 (1990); L. Jaeger, E. Westhof, F. Michel, ibid 221, 1153 (1991).
41. F Michel and E Westhof, J Mol. Biol. 216, 585 (1990); L. Jaeger, E. Westhof, F. Michel, ibid 221, 1153 (1991).
42. CBP2 state (4)
43. We thank P. Bevilacqua for discussion. Supported by a fellowship from the Jane Coffin Childs Memorial Fund for Medical Research (K.M.W.) and by the Howard Hughes Medical Institute (T.R.C.).